Effective delivery of Complex Innovative Design (CID) cancer trials—A consensus statementSarah P. Blagden, A. Yiangou, Alison M. Cooper et al.|British Journal of Cancer|2020Cited by 44
Additional consensus recommendations for conducting complex innovative trials of oncology agents: a post-pandemic perspectiveSarah P. Blagden, Louise Brown, Ly‐Mee Yu et al.|British Journal of Cancer|2022Cited by 2